Huron Consulting Group Inc. reports developments tied to its work as a global professional services firm serving clients through Healthcare, Education and Commercial operating segments. Company news commonly covers financial results, revenue before reimbursable expenses, annual guidance, segment performance, and demand for services in strategy, operations, advisory, analytics and digital transformation.
Recurring updates also include completed acquisitions that expand Huron's healthcare and technology-enabled consulting capabilities, governance changes involving the board of directors, senior-level promotions, workplace recognition and earnings webcast schedules. Healthcare is a major reporting focus, including services for providers, payors and organizations modernizing operations and technology platforms.
Huron (HURN) has been named one of Consulting Magazine's 2026 Best Firms to Work For, its 16th consecutive year receiving this employee-driven recognition.
The award is based on comprehensive employee survey feedback on culture, career development, client engagement, compensation and benefits, leadership, and work-life balance. Huron highlights ongoing investments in leadership development, mentorship, career advancement, and inclusion programs that it says foster a high-performing, collaborative workplace and support strong client results. The firm notes this honor adds to a growing list of workplace and employer-brand awards.
Huron (Nasdaq: HURN) reported record Q2 2026 revenues before reimbursable expenses (RBR) of $465.6 million, up 15.7% year over year, with organic RBR growth of 10.8% excluding $19.5 million from acquisitions. Net income rose 60.8% to $31.2 million, and diluted EPS increased 75.2% to $1.91. Adjusted EBITDA grew 19.9% to $72.6 million (15.6% of RBR), while adjusted diluted EPS increased 30.2% to $2.46. Operating cash flow increased 50.5% to $120.5 million.
For the first half of 2026, RBR rose 13.9% to $909.3 million with 9.1% organic growth, and adjusted EBITDA reached $123.2 million (13.6% of RBR). Huron repurchased $208.6 million of stock year-to-date (9.0% of shares as of December 31, 2025). The company raised 2026 RBR guidance to $1.85–$1.89 billion, with adjusted EBITDA margin expected at 14.5%–15.0% and adjusted diluted EPS at $9.00–$9.40.
Huron (NASDAQ: HURN) has elected Dr. L. Thomas Richards to its Board of Directors, effective July 23, 2026, bringing the board size to 10 members. According to Huron, Richards adds deep experience in life sciences and healthcare, capital markets, innovation and corporate governance.
Richards has held leadership roles at WittKieffer, One Biomed and TessArae, advised venture and private equity investors, practiced academic emergency medicine at Stanford and UCSF, and worked in M&A investment banking at Lazard Frères, UBS and SG Cowen. He holds degrees from Harvard Medical School, the University of Sydney and Yale.
Huron (NASDAQ:HURN) will release its financial results for the second quarter ended June 30, 2026, after the market closes on Tuesday, July 28, 2026. CEO and president C. Mark Hussey and CFO John D. Kelly will host a webcasted conference call at 5:00 p.m. ET (4:00 p.m. CT), accessible via Huron’s investor relations website. A replay will be available about two hours after the call and will remain online for 90 days.
Huron (NASDAQ:HURN) announced that three senior leaders were named 2026 Consulting Magazine Top Consultants. John DiDonato received the Lifetime Achievement Award, while Paul Praveen was honored for Global & Cross-Border Consulting and Andy Waldeck for Strategy and Transformation, highlighting leadership, innovation, and client impact.
Huron (NASDAQ:HURN) elected Shoshana Vernick to its Board of Directors, effective June 19, 2026, increasing the board to nine members. Vernick is co-founder and managing partner of Avathon Capital and brings extensive education-sector, investment, governance and technology-enabled growth experience to support Huron’s long-term growth strategy.
Huron (NASDAQ:HURN) announced the acquisition of RelateCare, a provider of AI-enabled clinical and patient access solutions. The deal aims to expand Huron’s healthcare managed services, improving patient access, care coordination, and operational performance across the patient journey. RelateCare will report within Huron’s Healthcare segment; transaction terms were not disclosed.
Huron (Nasdaq: HURN) reported Q1 2026 results: RBR $443.7M (up 12.1% YoY), net income $23.2M, adjusted EBITDA $50.6M (11.4% of RBR) and adjusted diluted EPS $1.73. The company repurchased $155.5M of stock (1.1M shares) and affirmed full‑year 2026 guidance: RBR $1.78B–$1.86B, adjusted EBITDA margin 14.5%–15.0% and adjusted diluted EPS $8.35–$9.15.
Organic RBR growth was 7.3% after excluding acquisitions; utilization mixed across capabilities and headcount rose to support demand.
Huron (NASDAQ: HURN) will report Q1 2026 results for the quarter ended March 31, 2026, after market close on Tuesday, May 5, 2026. A conference call and webcast with CEO C. Mark Hussey and CFO John D. Kelly will be held May 5, 2026 at 5:00 p.m. ET.
A replay will be available about two hours after the webcast and accessible for 90 days on Huron's investor website.
Huron (NASDAQ: HURN) earned Great Place To Work Certification™ in the United States, Canada, India, Singapore, and the United Kingdom for the second consecutive year on April 14, 2026.
According to the company, 87% of employees say Huron is a great place to work; the firm cites investments in leadership development, flexible work, and well-being programs.